Pamela B. Allen

Pamela B. Allen

Anesthesiology
1365 Clifton Road Northeast
Atlanta, GA 30322

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications

Clinicopathologic Features and Long-Term Outcomes of Adult Hypopigmented Mycosis Fungoides.

Clinicopathologic Features and Long-Term Outcomes of Adult Hypopigmented Mycosis Fungoides.

Journal: JAMA dermatology
Published: June 17, 2026

Health disparities in narrowband UVB phototherapy for mycosis fungoides: A multi-institutional cohort study across Fitzpatrick skin types.

Health disparities in narrowband UVB phototherapy for mycosis fungoides: A multi-institutional cohort study across Fitzpatrick skin types.

Journal: Journal of the American Academy of Dermatology
Published: November 12, 2025

Patterns of Care and Clinical Outcomes in Systemic Peripheral T-cell Lymphoma: The LEO-MER Prospective Cohort Study.

Patterns of Care and Clinical Outcomes in Systemic Peripheral T-cell Lymphoma: The LEO-MER Prospective Cohort Study.

Journal: Blood advances
Published: September 17, 2025

Racial and Socioeconomic Disparities in Cutaneous T-Cell Lymphoma Survival: Insights From the National Cancer Database.

Racial and Socioeconomic Disparities in Cutaneous T-Cell Lymphoma Survival: Insights From the National Cancer Database.

Journal: Clinical lymphoma, myeloma & leukemia
Published: February 10, 2025

Racial differences in mycosis fungoides and Sézary syndrome: A multicenter cohort study.

Racial differences in mycosis fungoides and Sézary syndrome: A multicenter cohort study.

Journal: Journal of the American Academy of Dermatology
Published: January 16, 2025

Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma.

Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 19, 2024

Advances in Novel Systemic Therapies for the Management of Cutaneous T Cell Lymphoma (CTCL).

Advances in Novel Systemic Therapies for the Management of Cutaneous T Cell Lymphoma (CTCL).

Journal: Current hematologic malignancy reports
Published: October 17, 2024

ASTCT and USCLC clinical practice recommendations for allogeneic stem cell transplant in mycosis fungoides and Sézary syndrome.

ASTCT and USCLC clinical practice recommendations for allogeneic stem cell transplant in mycosis fungoides and Sézary syndrome.

Journal: Journal of the American Academy of Dermatology
Published: September 19, 2024

ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome.

ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome.

Journal: Transplantation and cellular therapy
Published: August 25, 2024

Fifteen-Year Experience of a Single Institution: Outcomes for Early-Stage Hodgkins Lymphoma Comparing Chemotherapy Alone Versus Combined Modality Therapy.

Fifteen-Year Experience of a Single Institution: Outcomes for Early-Stage Hodgkins Lymphoma Comparing Chemotherapy Alone Versus Combined Modality Therapy.

Journal: Advances in radiation oncology
Published: April 09, 2024

The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas.

The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas.

Journal: Blood advances
Published: January 29, 2024

Cutaneous T-cell lymphoma with CNS involvement: a case series and review of the literature.

Cutaneous T-cell lymphoma with CNS involvement: a case series and review of the literature.

Journal: CNS oncology
Published: October 25, 2023
Showing 1-12 of 46

Last Updated: 09/26/2026